Overview

Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study

Status:
Completed

Trial end date:
2016-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether Quillivant XR is effective in the treatment of ADHD in children with Autism Spectrum Disorder (ASD).

Phase:

Phase 4

Details

Lead Sponsor:

Seattle Children's Hospital

Collaborator:

Pfizer

Treatments:

Methylphenidate